The association of HLA-DQ7 with bullous pemphigoid is restricted to men

British Journal of Dermatology

Volumn 138, Issue 6, 1998, Pages 1085-1090

  Banfield, C C ^a,b   Wojnarowska, F ^a   Allen, J ^a   George, S ^a   Venning, V A ^a   Welsh, K I ^a  

^a CHURCHILL HOSPITAL   (United Kingdom)

^b STOKE MANDEVILLE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CLOBETASOL PROPIONATE; HLA DQ ANTIGEN; MINOCYCLINE; NICOTINAMIDE; PREDNISOLONE; SULFONAMIDE;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HLA SYSTEM; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; MOUTH MUCOSA; ORAL DRUG ADMINISTRATION; PEMPHIGOID; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; TOPICAL DRUG ADMINISTRATION;

AGED; AGED, 80 AND OVER; FEMALE; HLA-DQ ANTIGENS; HUMANS; MALE; MIDDLE AGED; PEMPHIGOID, BULLOUS; SEX FACTORS;

EID: 0031749661     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1998.02350.x     Document Type: Article

References (15)

1. Mueller S, Klaus-Kovutun V, Stanley J. A 230kD protein is the major BP antigen. J Invest Dermatol 1989; 92: 33-8.
2. Giudice GJ, Squiquera HL, Elias PM et al. Identification of two collagen domains within the bullous pemphigoid autoantigen. BP180. J Clin Invest 1991; 87: 734-8.
3. Liu Z, Giudice GJ, Swartz SJ et al. The role of complement in experimental bullous pemphigoid. J Clin Invest 1995; 95: 1539-44.
4. Taylor G, Venning VA, Wojnarowska FT et al. Bullous pemphigoid and autoimmunity. J Am Acad Dermatol 1993; 29: 181-1.
5. Tussey LG, McMichael AJ. General introduction to the MHC. In: Modulation of the MHC Antigen Expression and Disease (Blair GE, Pringle CR, Maudsley DJ, eds ). Cambridge: Cambridge University Press. 1995: 1-25.
6. Ragoussis J. Organization of the MHC. In: Modulation of the MHC Antigen Expression and Disease (Blair GE, Pringle CR, Maudsley DJ. eds ). Cambridge: Cambridge University Press. 1995: 27-42.
7. Venning VA, Taylor CJ, Ting A et al. HLA type in bullous pemphigoid, cicatricial pemphigoid and linear IgA disease. Clin Exp Dermatol 1989; 14: 283-5.
8. Ahmed AR, Foster S, Zaltas M et al. Association of DQw7 (DQB1*0301) with ocular cicatricial pemphigoid. Pror Natl Acad Sci USA 1991; 88: 11579-82.
9. Schaller J, Feleke W, Haustein UF et al. HLA in bullous pemphigoid. The probable role of HLA-B7 as a marker for poor responders Io immunosuppressive therapy. Int J Dermatol 1991; 30: 36-8.
10. Yunis JJ, Mobini N, Yunis EJ et al. Common major histocompatibility complex class II markers in clinical variants of cicatricial pemphigoid. Proc Natl Acad Sci USA 1994; 91: 7747-51.
11. Delgado JC, Turbay D, Yunis EJ et al. A common major histocompatibility complex class II allele HLA-DQB*0301 is present in clinical variants of pemphigoid. Proc Natl Acad Sci USA 1996; 93: 8569-71.
12. Marren P, Yell J, Charnock FM et al. The association between lichen sclerosus and antigens of the HLA system. Br J Dermatol 1995; 132: 197-203.
13. Bunce M, O'Neill CM, Barnardo MCNM et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 &DQB1 by PCR with 144 primer mixes utilizing sequence specific primers (PCR-SSP). Tissue Antigens 1995; 46: 355-67.
14. Bunce M, Barnardo MCMW, Procter J et al. High resolution HLA-C typing by PCR-SSP. Identification of allelic frequencies and linkage disequilibria in 604 unrelated random UK caucasians and a comparison with serology. Tissue Antigens 1996; 48: 680-91.
15. Chan LS, Hammerberg C, Cooper KD. Significantly increased occurrence of HLA-DQB*0301 allele in patients with ocular cicatricial pemphigoid. J Invest Dermatol 1997; 108: 129-32.